Brief: Genmab Says Nine Months Revenue Increases 21% To $2,662 Million
Nov 6 (Reuters) - Genmab A/S GMAB.CO: GENMAB - 9M REVENUE INCREASES 21% TO $2,662 MILLION GENMAB - MAINTAINING ITS 2025 FINANCIAL GUIDANCE Source text: ID:nGNE12Ppkn Further company coverage: GMAB.CO ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Genmab A/S
See all newsBrief: Genmab Q3 Net Sales Of Darzalex At $4.24 Bln
European shares rise as retreating bond yields and oil prices boost risk appetite
Live Markets: Oil prices can rise even with a new MoU
Live Markets: What the AI capex cycle might mean for European growth
Live Markets: Ignore politics and buy the dip in Spain's Bonos